Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
Tullio Palmerini(University of Bologna), Gregg W. Stone(Cardiovascular Research Foundation), Philippe Gabríel Steg(Sorbonne Paris Cité), Byeong‐Keuk Kim(Ewha Womans University), Philippe Généreux(Morristown Medical Center), Yangsoo Jang(Yonsei University), Deepak L. Bhatt(Brigham and Women's Hospital), Adnan Kastrati, Martine Gilard(Centre Hospitalier Régional Universitaire de Brest), Alaide Chieffo, Gilles Montalescot(Sorbonne Université), Stefanie Schüpke, Antonio Colombo(Memorial Hermann), Marco Valgimigli(University of Bern), Alexandre Abizaid(Instituto Dante Pazzanese de Cardiologia), Hyo‐Soo Kim(Seoul National University), Myeong‐Ki Hong(Ulsan College), Jung‐Min Ahn(University of Ulsan), Abdourahmane Diallo(Assistance Publique – Hôpitaux de Paris), Mattia Romanello(University of Bologna), Giuseppe Biondi‐Zoccai(Sapienza University of Rome), Diego Della Riva(University of Bologna), Fausto Feres(Instituto Dante Pazzanese de Cardiologia), Maria Letizia Bacchi Reggiani, Éric Vicaut(Assistance Publique – Hôpitaux de Paris), Yaling Han(Northern Hospital), Bo Xu(San Raffaele University of Rome), Seung‐Jung Park(Samsung Medical Center), Gérard Helft(Sorbonne Université), Marie-Claude Morice(Institut Cardiovasculaire Paris Sud), Kyung Woo Park(Boston University)
Cited by 146
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k